AzTrials
AzTrials

Congenital Heart DiseaseLbHNCT06267430

Learning by Heart: The Effectiveness of an EF Training Program for Pre-schoolers With Critical CHD

A study testing Kleuter Extra training program in people with Congenital Heart Disease and Executive Dysfunction, run by Erasmus Medical Center at 3 sites in Netherlands.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Advances in prenatal and neonatal care have improved outcomes in children with critical congenital heart disease (CCHD). With the increase in survival, neurocognitive problems such as executive functioning (EF) impairments have become more apparent in these children. Read more about this study

Who is it for?
Ages 4 to 7 years
What is being tested?
Kleuter Extra training program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
103 participants
Where
3 sitesNetherlands
Study dates
1 May 2024to 31 Oct 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 7 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

None listed.

Who cannot join

  • Children with severe brain damage (estimated IQ < 55)
  • Genetic syndromes known to directly affect cognitive performance (e.g. Down syndrome)
  • Children with severe psychiatric disorders upon inclusion that require treatment first, such as a posttraumatic stress disorder, separation anxiety disorder, or reactive attachment disorder.

Trial locations and contacts

3 sites in 1 country.

Netherlands3 sites
  • University Medical Center - Beatrix children&#39;s hospital Groningen

    Groningen, Provincie Groningen, 9713GZ

  • Erasmus Medical Center Sophia Children&#39;s Hospital

    Rotterdam, Rotterdam, 3015CN

  • University Medical Center - Wilhelmina children's hospital Utrecht

    Utrecht, Utrecht, 3584EA

Other trials in Netherlands

About this study

Official title: The Effectiveness of a Personalized Executive Functioning Training Program for Pre-schoolers With a Critical Congenital Heart Disease

Advances in prenatal and neonatal care have improved outcomes in children with critical congenital heart disease (CCHD). With the increase in survival, neurocognitive problems such as executive functioning (EF) impairments have become more apparent in these children. EF problems have cascading negative effects on a child's development. New insights in EF development suggest that in otherwise physically healthy young children, EF can be improved by training. In a pilot study funded by Stichting Hartekind, the investigators studied the feasibility of a personalized EF training program called 'Kleuter Extra' and the results were promising. Therefore, the current study will investigate the effectiveness of this program in 4-6-year-old children with CCHD. The researchers will also explore interactions between the parent-child relationship and EF development of the child as psychosocial difficulties in these children and their parent(s) and/or caretaker(s) may impact EF-development. If found effective, EF training for children with CCHD will improve their developmental outcome.

Read the detailed description

Advances in prenatal and neonatal care have improved outcome in children with critical congenital heart disease (CCHD), with survival rates up to 90%. With the increase in survival, neurocognitive problems and psychological maladjustment have become more apparent in these children, such as impairments in their executive functioning. Executive functioning (EF) is an umbrella-term for several higher-order cognitive processes crucial for self-regulated and goal directed behavior. Frequently postulated components of EF are inhibition, including motor inhibition, and attention, working memory, and cognitive flexibility. Early EF problems often result in emotion regulation difficulties, behavioural problems, social problems, and learning problems, which can lead to diminished functioning in social domains and lower achievement levels in education and employment status. Children with CHD might be rendered even more vulnerable for EF-problems since EF development is embedded within the social context of a child. There is an increasing understanding of how naturally distressing the CHD diagnosis and treatment can be for parents, which can impair the interactions with their child and in turn might negatively impact the child's EF development. Looking at the reciprocal nature of relationships, the child's illness and/or emotional and behavioural problems that may be associated with EF difficulties might negatively impact the parent-child relationship, parenting behaviour and parental wellbeing. However, these relations are poorly understood, especially regarding fathers. A greater understanding of the interplay between biological and psychosocial factors on EF-development is needed to promote optimal developmental outcomes for these vulnerable children.

New insights suggest that EF can be improved by training. Due to neural plasticity, the window for effective training seems to be between the ages of two and six years. After this time frame, improvements in EF may not retain after training or not generalize to off-task functions. Current EF training programs are not personalised ('adaptive') but offer the same program regardless of the specific child's EF dysfunctions, which may explain their limited effects. There is presently no effective EF training program for children with CHD.

In a pilot study funded by Stichting Hartekind, the researchers investigated the feasibility of a personalised EF training program called 'KleuterExtra' in 4-6 year old children with critical CHD. Within a week, 31 children were (self-) referred for the study, indicating a great clinical need. Directly after training, children showed clinically relevant improvement on the specific EFs targeted in training, with Cohen's d effect sizes ranging from 0.19 to 2.41 (>1.00 on 5 out of 9 tasks). Improvement was also found in untrained EFs and tasks that combined multiple EFs, indicating a generalization effect. Parents and teachers spontaneously reported positive results in daily life. Based on these promising results, the investigators designed the current randomized, controlled study to test the effectiveness of this training program in pre-schoolers with severe CHD.

Given the above, the investigators designed this study to investigate the effectiveness of a tailored EF training program for preschoolers with CCHD. Secondary aim was to explore interactions between the parent-child relationship and the EF development of the child. If found effective, EF training for children with CCHD will improve their developmental outcome.

Being tested
Kleuter Extra training program
Keywords
Congenital heart disease, Preschooler, Executive functions, Training
Medical subject headings
Heart Defects, Congenital, Cognition Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Kleuter Extra training programBehavioural

    The intervention was described in the included arm/group explanation.

Study groups in NCT06267430
Study groupRoleWhat they receive
Intervention groupExperimentalThe participants allocated to the intervention group will receive the personalised training program 'KleuterExtra', developed by dr. Lex Wijnroks from Utrecht University. All parents will receive the book 'Speels Brein' ('Playful Brain') and an age-appropriate addition for preschoolers to this book.
Receives: Behavioral: Kleuter Extra training program
Control groupNo interventionAs described, the parents of the control group will also receive the book 'Speels Brein' ('Playful Brain') and the age-appropriate addition for preschoolers to this book.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Kleuter Extra test battery

    The primary endpoint is a single composite score on the 'KleuterExtra' EF test battery, calculated as the mean z-score (mean = 0, SD = 1) of the ten tasks of the test battery. The composite score has no fixed minimum or maximum, and a higher score indicates a better outcome.

    Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.

Secondary outcomes (11)
  1. EF functioning

    Scores on the 10 individual tasks of the 'KleuterExtra' test battery, four EF domain scores (inhibition, attention, working memory, cognitive flexibility), and an integrated EF score (based on task 'Head-Toes-Knees-Shoulders'; HTKS).

    Raw task scores:

    • 'Pencil Tap': 0 to 100
    • 'Go/No go animals': 0 to 20
    • 'Statue task': 0 to 30
    • 'Search task': 0 to 18
    • 'Sustained attention': 0 to 30
    • 'Corsi blocks': 0 to 15
    • 'Dots': 0 to 74
    • 'Digit Recall': 0 to 54
    • 'Three is Correct': 0 to 68
    • 'HTKS': 0 to 52

    A higher score indicates a better outcome for all tasks, except 'Go/No go animals' (reverse scored). Raw scores are converted to z-scores (mean = 0, SD =1) for analysis. A higher z-score indicates a better outcome. Domain scores are calculated as the mean z-score of the tasks within each domain.

    Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.

  2. Information processing

    Cognitive Proficiency Index of the WPPSI-IV-NL: index score (mean = 100, SD =15, range 40-160), and a higher score indicates a better outcome. The CPI is based on four subtests (scaled scores 1-19):

    • subtest 'Picture Memory'
    • subtest 'Zoo Locations'
    • subtest 'Bug Search'
    • subtest 'Cancellation'

    Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.

  3. Executive functioning in daily life - completed by the parent(s)

    Behavior Rating Inventory of Executive Function - Preschool Version questionnaire (BRIEF-P): t-scores range from 20-80, higher scores indicate worse outcome. The three calculated main indexes (inhibitory self-control, flexibility, and metacognition) will be used for the current trial.

    Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.

  4. Behavioral and emotional difficulties of the child - completed by the parent(s)

    Child Behavioral Checklist questionnaire 1,5 - 5 years old (CBCL): t-scores range from 50-100, higher scores indicate worse outcome. The three overall domains (internalizing behavior, externalizing behavior, and the total sum of problems) will be used for the current trial.

    Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.

  5. Quality of the child's life - completed by the parent(s)

    Preschool Children Quality of Life questionnaire (TAPQOL): scale scores range from 0 - 100, higher score indicates better outcome. All twelve scales will be used for the current trial: stomach problems, skin problems, lung problems, sleeping problems, appetite, problem behavior, positive mood, anxiety, liveliness, social functioning, motor functioning, and communication.

    Measured: 9 weeks after baseline, additional measures at 6 months and 12 months after baseline.

  6. Emotional distress parent - completed by the parent(s)

    Depression, Anxiety, Stress Scale (DASS-21): subscale scores (depression, anxiety, stress) range from 0-21 and the total score ranges from 0-63. A higher score indicates worse outcome. These four scales will be used for this trial.

    Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.

  7. Parental trauma

    PCL-5 questionnaire ('PCL-5' is the title, scores range from 0-80, higher score indicates worse outcome)

    Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.

  8. Parenting behavior questionnaire - completed by the parent(s)

    Parenting Behavior questionnaire (PABI; Dutch title 'Vragenlijst over opvoedgedrag'): T-scores range from 20-80. The three adaptive domains (warmth, structure, and autonomy), and three maladaptive domains (hostility, coercion, and excessive protection) will be used for the current trial. Higher scores indicate a better outcome on the adaptive domains, and a worse outcome on the maladaptive domains.

    Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.

  9. Child demographics: schooling - completed by the parents

    Additional support in school, type, being held back a year (qualitative data, designed by the study group)

    Measured: Baseline. Changes are recorded at 9 weeks, 6 months, and 12 months after baseline.

  10. Behavioral and emotional difficulties teacher's perspective

    Teacher's Report Form questionnaire (C-TRF): t-scores range from 50-100, higher scores indicate worse outcome. The three overall domains (internalizing behavior, externalizing behavior, and the total sum of problems) will be used for the current trial.

    Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.

  11. Executive functioning child in daily life teacher's perspective

    Behavior Rating Inventory of Executive Function questionnaire - teachers (BRIEF-P); t-scores range from 20-80, higher scores indicate worse outcome.

    Measured: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2024
  2. Study start1 May 2024
  3. Primary completion29 Oct 2025
  4. Study completion31 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
103 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06267430
Sponsor's protocol ID
NL85141.078.23
Acronym
LbH
Status last verified
Oct 2026
First submitted
12 Dec 2023
Last updated
9 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Kleuter Extra training program in people with Congenital Heart Disease and Executive Dysfunction, run by Erasmus Medical Center at 3 sites in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 9 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Kleuter Extra test battery (time frame: 9 weeks after baseline. Additional measures at 6 months and 12 months after baseline.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
LbH Clinical Trial NCT06267430 | AzTrials